Aprea Therapeutics secures up to $34 million in financing By Investing.com
© Reuters.
DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ:), a biopharmaceutical company specializing in precision oncology, announced today that it has entered into a securities purchase agreement with healthcare-focused…